Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research

Showing results (501-510 of 49,955) with videos related to

Pageof 4,996
Sort By:
Cancer Research|October 19, 2001
The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesisR Fishel
Cancer Research|August 2, 2001
Selective estrogen receptor modulation: a personal perspectiveV C Jordan
Cancer Research|August 2, 2001
Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancerM Schindl, G Oberhuber, A Obermair, et al.
Cancer Research|August 2, 2001
Aberrant methylation and simian virus 40 tag sequences in malignant mesotheliomaS Toyooka, H I Pass, N Shivapurkar, et al.
Cancer Research|August 2, 2001
Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell lineG Liu, A Bode, W Y Ma, et al.
Cancer Research|August 2, 2001
Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosisT Sjöblom, A Shimizu, K P O'Brien, et al.
Cancer Research|August 2, 2001
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptorC Sánchez, M L de Ceballos, T Gomez del Pulgar, et al.
Cancer Research|August 2, 2001
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitorsR B Lichtner, A Menrad, A Sommer, et al.
Cancer Research|August 2, 2001
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cellsM Kavallaris, A S Tait, B J Walsh, et al.
Cancer Research|August 2, 2001
Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligandU Naumann, S Kügler, H Wolburg, et al.
Pageof 4,996

Showing results (501-510 of 49,955) with videos related to

Sort By:
Pageof 4,996
Cancer Research|October 19, 2001
The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesisR Fishel
Cancer Research|August 2, 2001
Selective estrogen receptor modulation: a personal perspectiveV C Jordan
Cancer Research|August 2, 2001
Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancerM Schindl, G Oberhuber, A Obermair, et al.
Cancer Research|August 2, 2001
Aberrant methylation and simian virus 40 tag sequences in malignant mesotheliomaS Toyooka, H I Pass, N Shivapurkar, et al.
Cancer Research|August 2, 2001
Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell lineG Liu, A Bode, W Y Ma, et al.
Cancer Research|August 2, 2001
Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosisT Sjöblom, A Shimizu, K P O'Brien, et al.
Cancer Research|August 2, 2001
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptorC Sánchez, M L de Ceballos, T Gomez del Pulgar, et al.
Cancer Research|August 2, 2001
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitorsR B Lichtner, A Menrad, A Sommer, et al.
Cancer Research|August 2, 2001
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cellsM Kavallaris, A S Tait, B J Walsh, et al.
Cancer Research|August 2, 2001
Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligandU Naumann, S Kügler, H Wolburg, et al.
Pageof 4,996